Solution
Its excellent efficacy and good safety have brought a new treatment strategy vascular repair therapy for interventional cardiology, and will lead the fourth revolution of interventional therapy for heart disease。
Xinsorb stent has been in clinical research for the first time in China, completed a large number of clinical trials, and entered the special approval process of national innovative medical devices。
A leader in high-end innovative healthcare solutions
The new generation of biodegradable rapamycin eluting stent "xinsorb" independently developed by the company is an ideal cardiovascular stent to solve the late thrombosis of metal stent. Xinsorb stent has been in clinical research for the first time in China, completed a large number of clinical trials, and entered the special approval process of national innovative medical devices。
